Propranolol and ascorbic acid in control of fibrodysplasia ossificans progressiva flare-ups due to accidental falls-Reference-Cited by-同舟云学术

Propranolol and ascorbic acid in control of fibrodysplasia ossificans progressiva flare-ups due to accidental falls

Published:2019-02-28 Issue:1 Volume:8 Page:24-28
ISSN:2186-361X
Container-title:Intractable & Rare Diseases Research
language:en
Short-container-title:IRDR

Author:

Palhares Durval Batista¹,Nascimento Deborah Ribeiro¹²,Palhares Marilene Garcia¹,Balaniuc Suzana Lopes Bomfim¹,Giuliani Liane de Rosso¹,Xavier Paula Cristhina Niz¹,Brum José Mauro Goulart³,Alves Fabiana⁴⁵,Vieira Francisco Oliveira⁴⁵,Souza-Fagundes Elaine Maria⁴,Underwood Adam⁶,Milsted Amy⁶,Santos Robson Augusto Souza⁴,Martins Almir Sousa⁴

Affiliation:

1. UFMS/ Faculty of Medicine

2. Medical Faculty of Barbacena, José Bonifácio Lafayette de Andrada Foundation

3. Procter & Gamble Health Care & Global Clinical Sciences

4. UFMG/ Department of Physiology and Biophysics

5. Centro Universitário Metodista Izabela Hendrix- IMIH

6. The Walsh University, Division of Mathematics and Sciences

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/irdr/8/1/8_2018.01095/_pdf

Reference30 articles.

1. 1. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: Clinical and genetic aspects. Orphanet J Rare Dis. 2011; 6:80.

2. 2. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006; 38:525-527.

3. 3. Morales-Piga A, Bachiller-Corral J, Trujillo-Tiebas MJ, Villaverde-Hueso A, Gamir-Gamir ML, Alonso Ferreira V, Vázquez-Díaz M, Posada de la Paz M, AyusoGarcia C. Fibrodysplasia ossificans progressiva in Spain: Epidemiological, clinical, and genetic aspects. Bone. 2012; 51:748-755.

4. 4. Shimono K, Tung W, Macolino C, Chi A.H, Didizian JH, Mundy C, Chandraratna RA, Mishina Y, Enomoto-Iwamoto M, Pacifici M, Iwamoto M. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γagonists. Nat Med. 2011; 17:454-460.

5. 5. Clementia initiates Phase 2 extension study of palovarotene in FOP patients. News Medical Life Sciences. 2014. http://www.news-medical.net/news/20141027/Clementia-initiates-Phase-2-extension-study-of-palovarotene-in-FOP-patients.aspx (accessed May 05, 2018).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare and intractable fibrodysplasia ossificans progressiva shows different PBMC phenotype possibly modulated by ascorbic acid and propranolol treatment;Intractable & Rare Diseases Research;2021-08-31

2. Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients;Bone;2021-08

3. Evaluation of the Effects of ß-Adrenergic Receptor-Propranolol on Osseointegration of the Titanium Implants;Journal of Craniofacial Surgery;2020-09-04

4. Fibrodysplasia ossificans progressiva: lessons learned from a rare disease;Current Opinion in Pediatrics;2019-12